Guo Zhang
Capital Medical University
4 Papers
44 Citations
Guo Zhang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Liver biopsy & HBeAg. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase.
Jiyuan Zhou,Song Liuwei,Hong Zhao,Linlin Yan,Anlin Ma,Shibin Xie,Zhang X,Da-Zhi Zhang,Qing Xie,Guo Zhang,Jia Shang,Jun Cheng,Wei-Feng Zhao,Zhi-Qiang Zou,Mingxiang Zhang,Ningshao Xia,Guiqiang Wang,Guiqiang Wang +17 more
TL;DR: Serum anti-HBc showed a high diagnostic accuracy for predicting moderate-to-severe inflammation in both hepatitis B e antigen (HBeAg)-positive and HBeAg-negative CHB patients with normal ALT levels, and may be a strong indicator for assessing the hepatic inflammatory degree and used for antiviral treatment decisions in CHB Patients with normalALT levels.
Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases.
Yongqiong Deng,Hong Zhao,Anlin Ma,Jiyuan Zhou,Shibin Xie,Zhang X,Da-Zhi Zhang,Qing Xie,Guo Zhang,Jia Shang,Jun Cheng,Wei-Feng Zhao,Zhi-Qiang Zou,Mingxiang Zhang,Guiqiang Wang +14 more
TL;DR: CXCL-11 was independently associated with at least moderate inflammation, whereas IL-2R and TGF-&agr; were independent indicators of significant fibrosis in both, total CHB patients and patients with normal or mildly elevated ALT.
38
Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection
Liang Miao,Wanna Yang,Xiaoqin Dong,Zhanqing Zhang,Shibin Xie,Da-zhi Zhang,Zhang X,Jun Cheng,Guo Zhang,Wei-Feng Zhao,Qing Xie,Yingxia Liu,Anlin Ma,Jun Li,Jia Shang,Lang Bai,Li-Hua Cao,Zhi-Qiang Zou,Jiabin Li,Fudong Lyu,Hui Liu,Zhi-Jin Wang,Mingxiang Zhang,Li-Ming Chen,Wei-Feng Liang,Hui Gao,Hui Zhuang,Hong Zhao,Guiqiang Wang +28 more
TL;DR: Combined anluohuaxianwan and entecavir treatment can significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection and has the tendency to improve the stability rate and reduce the rate of progression of Liver fibrosis.
12
Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection: a prospective multi-center clinical study.
Jun Li,Xiaoqin Dong,Zhao Wu,Anlin Ma,Shibin Xie,Zhang X,Zhanqing Zhang,Da-Zhi Zhang,Wei-Feng Zhao,Guo Zhang,Jun Cheng,Qing Xie,Zhi-Qiang Zou,Ying-Xia Liu,Guiqiang Wang,Guiqiang Wang,Hong Zhao +16 more
TL;DR: Adult patients with MTCT were more prone to severe liver diseases, and the therapeutic efficacy was relatively poor, which underlined the importance of earlier, long-term treatment and interrupting perinatal transmission.